FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs – fda.gov

1. FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs  fda.gov
2. US set to speed up approval for some generic drugs in blow to Big Pharma  Financial Times
3. FDA’s biosimilars director says agency seeks to ‘streamline’ development  

Continue Reading